Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969962 | 0.90 | CNR2 (0.63) | CNR2KCNH2CNR1 | |
| SCHEMBL4969924 | 0.90 | CNR2 (0.69) | CNR2KCNH2CNR1 | |
| SCHEMBL4968579 | 0.90 | CNR2 (0.68) | CNR2KCNH2CNR1 | |
| SCHEMBL5438637 | 0.90 | CNR2 (0.53) | CNR2KCNH2CNR1 | |
| SCHEMBL5006444 | 0.84 | CNR2 (0.52) | CNR2KCNH2CNR1 | |
| SCHEMBL4968367 | 0.83 | CNR2 (0.59) | CNR2CNR1 | |
| SCHEMBL4966087 | 0.82 | CNR2 (0.70) | CNR2KCNH2CNR1 | |
| SCHEMBL14116725 | 0.82 | CNR2 (0.58) | CNR2CNR1 | |
| SCHEMBL4966746 | 0.82 | CNR2 (0.58) | CNR2CNR1 | |
| SCHEMBL5438354 | 0.82 | CNR2 (0.61) | CNR2KCNH2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070082899-A1 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | ASTRAZENECA AB (SE) | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082899-A1 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | F12, H1-3, H1-4 | CNR2 697/4885KCNH2 420/4885CNR1 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.